A Study of GZR18 Injection in Chinese Obese/Overweight Patients

Clinical trial NCT06256536 · COMPLETED

Trial details

NCT number: NCT06256536
Sponsor: Gan and Lee Pharmaceuticals, USA
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Obesity Overweight

Start date: 2022-07-14
Primary completion: 2023-10-22
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.